Jesper Brok

10.3k total citations · 5 hit papers
86 papers, 6.7k citations indexed

About

Jesper Brok is a scholar working on Pediatrics, Perinatology and Child Health, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Jesper Brok has authored 86 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pediatrics, Perinatology and Child Health, 28 papers in Pulmonary and Respiratory Medicine and 26 papers in Epidemiology. Recurrent topics in Jesper Brok's work include Renal and related cancers (23 papers), Renal cell carcinoma treatment (15 papers) and Hepatitis B Virus Studies (12 papers). Jesper Brok is often cited by papers focused on Renal and related cancers (23 papers), Renal cell carcinoma treatment (15 papers) and Hepatitis B Virus Studies (12 papers). Jesper Brok collaborates with scholars based in Denmark, United Kingdom and Netherlands. Jesper Brok's co-authors include Christian Gluud, Jørn Wetterslev, Kristian Thorlund, Arash Afshari, Ann Merete Møller, Yan Gong, Nicholas A. Buckley, Elizabeth H. Boxall, Chuanfang Lee and Ole Pryds and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Cochrane Database of Systematic Reviews.

In The Last Decade

Jesper Brok

78 papers receiving 6.5k citations

Hit Papers

Trial sequential analysis may establish when firm evidenc... 2007 2026 2013 2019 2007 2008 2009 2008 2010 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
    2007 1.3k citations Jørn Wetterslev, Kristian Thorlund et al. profile →
  2. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses
    2008 806 citations Jesper Brok, Kristian Thorlund et al. profile →
  3. Estimating required information size by quantifying diversity in random-effects model meta-analyses
    2009 700 citations Jørn Wetterslev, Kristian Thorlund et al. profile →
  4. Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
    2008 690 citations Jesper Brok, Kristian Thorlund et al. International Journal of Epidemiology profile →
  5. Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis
    2010 421 citations Secher Nj, Ole Pryds et al. BJOG An International Journal of Obstetrics & Gynaecology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesper Brok Denmark 31 1.8k 1.4k 1.3k 1.2k 817 86 6.7k
Carla M. Prado Canada 63 1.5k 0.8× 3.1k 2.2× 1.5k 1.1× 1.0k 0.8× 810 1.0× 300 18.4k
Lindsay D. Plank New Zealand 51 1.8k 1.0× 3.0k 2.1× 1.0k 0.8× 973 0.8× 828 1.0× 193 8.9k
Miklos Z. Molnar United States 57 1.5k 0.8× 1.8k 1.3× 1.6k 1.2× 448 0.4× 1.3k 1.6× 288 10.5k
Julio Pascual Spain 52 1.3k 0.7× 2.8k 2.0× 1.1k 0.8× 265 0.2× 709 0.9× 319 9.3k
Daniel W. Byrne United States 43 1.1k 0.6× 2.0k 1.4× 1.1k 0.8× 168 0.1× 1.3k 1.6× 155 7.6k
Erzsébet Horváth–Puhó Denmark 39 1.2k 0.7× 1.4k 1.0× 706 0.5× 363 0.3× 1.7k 2.0× 215 7.0k
Ruth Milner Canada 39 1.3k 0.7× 887 0.6× 1.6k 1.2× 472 0.4× 348 0.4× 101 7.2k
Christopher S. Hollenbeak United States 47 1.8k 1.0× 3.7k 2.6× 1.6k 1.2× 161 0.1× 1000 1.2× 310 9.2k
Arved Weimann Germany 40 988 0.5× 4.8k 3.4× 1.8k 1.3× 1.3k 1.0× 864 1.1× 172 9.3k
Kiyohide Fushimi Japan 29 1.7k 0.9× 2.6k 1.8× 1.4k 1.1× 141 0.1× 1.2k 1.4× 302 8.1k

Countries citing papers authored by Jesper Brok

Since Specialization
Citations

This map shows the geographic impact of Jesper Brok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesper Brok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesper Brok more than expected).

Fields of papers citing papers by Jesper Brok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesper Brok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesper Brok. The network helps show where Jesper Brok may publish in the future.

Co-authorship network of co-authors of Jesper Brok

This figure shows the co-authorship network connecting the top 25 collaborators of Jesper Brok. A scholar is included among the top collaborators of Jesper Brok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesper Brok. Jesper Brok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sutton, Kathryn S., Amy L. Walz, Andrew J. Murphy, et al.. (2025). Remaining Challenges in the Treatment of Relapsed Wilms Tumor: Children's Oncology Group and International Society of Paediatric Oncology Perspectives. Pediatric Blood & Cancer. 72(8). e31790–e31790.
2.
Christiansen, Michael, et al.. (2025). Causes of neonatal mortality in the European Economic Area and Switzerland: a WHO-based analysis and systematic review. European Journal of Pediatrics. 184(10). 628–628.
3.
Borgwardt, Lise, Jesper Brok, Kim Francis Andersen, et al.. (2024). Performing [18F]MFBG Long–Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma. Journal of Nuclear Medicine. 65(8). 1286–1292. 9 indexed citations
4.
Rascon, Jelena, Sabine Taschner‐Mandl, Stefan Rutkowski, et al.. (2024). Twinning to reduce research and innovation inequalities in paediatric solid tumours across Europe. SHILAP Revista de lepidopterología. 3. 100153–100153.
5.
Ortiz, Michael V., Christa Koenig, Amy E. Armstrong, et al.. (2023). Advances in the clinical management of high‐risk Wilms tumors. Pediatric Blood & Cancer. 70(S2). e30342–e30342. 7 indexed citations
6.
Spreafico, Filippo, Barbara Selle, Estelle Thébaud, et al.. (2023). Targeted therapies in children with renal cell carcinoma (RCC): An International Society of Pediatric Oncology—Renal Tumor Study Group (SIOP‐RTSG)‐related retrospective descriptive study. Cancer Medicine. 13(1). e6782–e6782. 2 indexed citations
7.
Ortiz, Michael V., Christa Koenig, Amy E. Armstrong, et al.. (2023). Advances in the clinical management of high‐risk Wilms tumors. Pediatric Blood & Cancer. 70(3). 8 indexed citations
8.
Spreafico, Filippo, Ronald R. de Krijger, Jarno Drost, et al.. (2021). Prognostic Factors for Wilms Tumor Recurrence: A Review of the Literature. Cancers. 13(13). 3142–3142. 34 indexed citations
9.
Powis, Mark, Gordan Vujanić, Tom A. Watson, et al.. (2021). Surgical management, staging, and outcomes of Wilms tumours with intravascular extension: Results of the IMPORT study. Journal of Pediatric Surgery. 57(4). 572–578. 8 indexed citations
10.
Krogh, Niels Steen, Catherine Rechnitzer, Jesper Brok, et al.. (2020). Smartphone App to Self-Monitor Nausea During Pediatric Chemotherapy Treatment: User-Centered Design Process. JMIR mhealth and uhealth. 8(7). e18564–e18564. 19 indexed citations
11.
Brok, Jesper, Annelies M. C. Mavinkurve‐Groothuis, Jarno Drost, et al.. (2020). Unmet needs for relapsed or refractory Wilms tumour: Mapping the molecular features, exploring organoids and designing early phase trials – A collaborative SIOP-RTSG, COG and ITCC session at the first SIOPE meeting. European Journal of Cancer. 144. 113–122. 19 indexed citations
12.
Dalhoff, Kim, René Mathiasen, Kjeld Schmiegelow, et al.. (2020). Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 149. 102939–102939. 11 indexed citations
13.
Brok, Jesper, Marta López‐Yurda, Harm van Tinteren, et al.. (2018). Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group–International Society of Paediatric Oncology Wilms' tumour protocol database. The Lancet Oncology. 19(8). 1072–1081. 48 indexed citations
14.
Greisen, Gorm, et al.. (2015). Prophylactic Probiotics for Preterm Infants: A Systematic Review and Meta-Analysis of Observational Studies. Neonatology. 109(2). 105–112. 101 indexed citations
15.
Rechnitzer, Catherine, et al.. (2014). Recent Advances in Understanding the Etiology and Pathogenesis of Pediatric Germ Cell Tumors. Journal of Pediatric Hematology/Oncology. 36(4). 263–270. 27 indexed citations
16.
Nj, Secher, et al.. (2010). Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants-but are we convinced? Evaluation of an apparently conclusive meta-analysis with trial sequential analysis. BJOG An International Journal of Obstetrics & Gynaecology. 118(1). 1–5. 421 indexed citations breakdown →
17.
Afshari, Arash, Jesper Brok, Ann Merete Møller, & Jørn Wetterslev. (2010). Aerosolized prostacyclin for acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Cochrane Database of Systematic Reviews. CD007733–CD007733. 30 indexed citations
18.
Brok, Jesper, Kristian Thorlund, Jørn Wetterslev, & Christian Gluud. (2008). Apparently conclusive meta-analyses may be inconclusive—Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology. 38(1). 287–298. 690 indexed citations breakdown →
19.
Brok, Jesper, et al.. (2007). Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 25(10). 1153–1162. 47 indexed citations
20.
Lee, Chuanfang, Yan Gong, Jesper Brok, Elizabeth H. Boxall, & Christian Gluud. (2006). Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 332(7537). 328–336. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla M. Prado Breakdown of academic impact, for papers by Lindsay D. Plank Breakdown of academic impact, for papers by Miklos Z. Molnar Breakdown of academic impact, for papers by Julio Pascual Breakdown of academic impact, for papers by Daniel W. Byrne Breakdown of academic impact, for papers by Erzsébet Horváth–Puhó Breakdown of academic impact, for papers by Ruth Milner Breakdown of academic impact, for papers by Christopher S. Hollenbeak Breakdown of academic impact, for papers by Arved Weimann Breakdown of academic impact, for papers by Kiyohide Fushimi
Rankless by CCL
2026